CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation-Reference-Cited by-同舟云学术

CD19-targeted chimeric antigen receptor-modified T cells induce remission in patients with relapsed acute B lymphoblastic leukemia after umbilical cord blood transplantation

Published:2021-05-06 Issue: Volume:Publish Ahead of Print Page:
ISSN:2542-5641
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Xu Qian-Wen,Xu Hui,Xue Lei,Wang Min,Pan Gui-Wang,Zhang Xu-Han,Song Kai-Di,Yao Wen,Wan Xiang,Tong Juan,Liu Hui-Lan,Xu Han-Ying,Liu Xin,Zhu Xiao-Yu,Sun Zi-Min,Yang Lin,Wang Xing-Bing

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference5 articles.

1. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells;Lee;Biol Blood Marrow Transplant,2019

2. 1994 Consensus Conference on acute GVHD grading;Przepiorka;Bone Marrow Transplant,1995

3. National Institutes of Health Consensus Development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report;Jagasia;Biol Blood Marrow Transplant,2015

4. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: prevention, detection, and treatment;Rautenberg;Int J Mol Sci,2019

5. Graft-versus-leukemia effects of transplantation and donor lymphocytes;Kolb;Blood,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric antigen receptor-immune cells against solid tumors: Structures, mechanisms, recent advances, and future developments;Chinese Medical Journal;2023-08-28

2. Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia;Chinese Medical Journal;2023-07-18

3. Ferroptosis in acute leukemia;Chinese Medical Journal;2023-04-03

4. Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy;Anti-Cancer Drugs;2023-01-04